Covidien Announces Five-Year Results from the ClosureFast™ Long-Term European Multi-Center Study in Patients with Lower Limb Venous Disease Study Demonstrates Long-Term Durability of the ClosureFast™ ...
SAN JOSE, Calif., Aug. 14 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices forthe minimally invasive treatment of venous reflux disease, is enjoying ...
May 19, 2010 — Radiofrequency ablation (RFA) using ClosureFAST (VNUS) is similarly effective to laser for varicose veins but causes less postprocedural pain, according to the results of a randomized ...
Please provide your email address to receive an email when new articles are posted on . Patients with symptomatic refluxing great saphenous veins treated by a closure procedure or radiofrequency ...
DUBLIN - Feb. 10, 2015 - The ClosureFast(TM) endovenous radiofrequency ablation catheter from Medtronic plc (MDT) is safe and effective for the treatment of chronic venous insufficiency (CVI) over ...
September 26, 2006 -- The US Food and Drug Administration (FDA) has granted a clinical laboratory improvement amendment waiver for a portable lead test, thereby improving its availability and access, ...
12 month closure rates for the VenaSeal closure system comparable to radiofrequency ablation DUBLIN, Medtronic plc today announced the twelve-month results of the VeClose pivotal study, which ...
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast ® ...
Study Demonstrates Long-Term Durability of the ClosureFast™ Radiofrequency Ablation System for Treatment of Chronic Venous Insufficiency MANSFIELD, Mass.-- Covidien, a leading global provider of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results